Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05322954 · ClinicalTrials.gov registry record · Phase 1
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
A Phase 1 study of Substance Use Disorders and Substance-Related Disorders, sponsored by University of Wisconsin, Madison.
- Active
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT05322954 is a Phase 1 study of Substance Use Disorders and Substance-Related Disorders that is active but no longer recruiting, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05322954, a Phase 1 study of Substance Use Disorders and Substance-Related Disorders, is active but no longer recruiting, sponsored by University of Wisconsin, Madison.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be actively engaged in the study for up to 26 weeks.
Conditions Studied
Interventions
- DRUG Psilocybin
Study Locations (1)
Wisconsin
- University of Wisconsin - Madison
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2023-03-03 |
| Est. Completion | 2026-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05322954
The ClinicalTrials.gov registry entry for NCT05322954 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 500-participant average among 93 other Substance Use Disorders trials with a reported enrollment target (98% lower). The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Substance Use Disorders appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin is the first listed.
NCT05322954 reports 1 study location spanning 1 distinct geographic area - top geographies include Wisconsin.
Frequently Asked Questions
What is clinical trial NCT05322954 about?
NCT05322954 is a clinical study titled "Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder". The purpose of this research study is to investigate the safety and feasibility of two (2) oral doses of psilocybin when combined with behavioral support for methamphetamine use disorder (MUD). Participants have a diagnosis of methamphetamine use disorder (MUD). Participants can expect to be activel...
What is the current status of trial NCT05322954?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2023-03-03. Estimated completion is 2026-05.
What conditions does trial NCT05322954 study?
This clinical trial studies the following conditions: Substance Use Disorders, Substance-Related Disorders, Methamphetamine Use Disorder, Stimulant Use Disorder, Chemically-Induced Disorders.
What interventions are being tested in trial NCT05322954?
The interventions under investigation include: Psilocybin (DRUG).
Who is sponsoring clinical trial NCT05322954?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05322954 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Supporting Treatment Access and Recovery Through Linkage and Support
RECRUITING · NA
-
Development OF A Novel Peer Recovery Supporter Training Platform
RECRUITING · NA
-
Project I Test: Implementing HIV Testing in Opioid Treatment Programs
RECRUITING · NA
-
Testing Strategies to Improve Substance Misuse Prevention Research Use in State Policy Contexts
RECRUITING · NA
-
Families Left Behind
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.